SCHEMBL9051293

SCHEMBL9051293

CC1(C)CCC(C)(C)c2cc(C(=Cc3ccc(C(=O)O)cc3)Cc3ccccc3)ccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 15/20 0.66
RARG P13631 14/20 0.66
RXRA P19793 14/20 0.66
RARA P10276 10/20 0.66
CYP26A1 O43174 2/20 0.66
CYP3A4 P08684 2/20 0.66
KDM4E B2RXH2 1/20 0.66
NPC1 O15118 1/20 0.66
GMNN O75496 1/20 0.66
USP2 O75604 1/20 0.66
ALDH1A1 P00352 1/20 0.66
LMNA P02545 1/20 0.66
TP53 P04637 1/20 0.66
CYP1A2 P05177 1/20 0.66
POLB P06746 1/20 0.66
CYP2D6 P10635 1/20 0.66
NFKB1 P19838 1/20 0.66
CYP2C19 P33261 1/20 0.66
THPO P40225 1/20 0.66
MTOR P42345 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9051275 1.00 RARB (0.66) RARBRARGRXRARARACYP26A1
SCHEMBL31191741 1.00 RARB (0.66) RARBRARGRXRARARACYP26A1
SCHEMBL9051287 1.00 RARB (0.66) RARBRARGRXRARARACYP26A1
SCHEMBL31191744 0.84 RARG (0.48) RARBRARGRXRARARACYP26A1
SCHEMBL6511837 0.82 RXRA (0.65) RARBRARGRXRARARACYP26A1
SCHEMBL29816275 0.82 RXRA (0.65) RARBRARGRXRARARACYP26A1
SCHEMBL4587206 0.82 RXRA (0.65) RARBRARGRXRARARACYP26A1
SCHEMBL7949412 0.81 RXRA (0.71) RARBRARGRXRARARACYP26A1
SCHEMBL29836848 0.80 RARB (1.00) RARBRARGRXRARARACYP26A1
SCHEMBL345071 0.80 RARB (1.00) RARBRARGRXRARARACYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911356-B2 Regulation of mutant TERT by BRAF V600E/map kinase pathway through FOS/GABP in human cancer THE JOHNS HOPKINS UNIVERSITY (US) 2024-02-27 US claimed
US-20200323805-A1 REGULATION OF MUTANT TERT BY BRAF V600E/MAP KINASE PATHWAY THROUGH FOS/GABP IN HUMAN CANCER THE JOHNS HOPKINS UNIVERSITY 2020-10-15 US claimed
US-20240366544-A1 REGULATION OF MUTANT TERT BY BRAF V600E/MAP KINASE PATHWAY THROUGH FOS/GABP IN HUMAN CANCER UNIV JOHNS HOPKINS (US) 2024-11-07 US disclosed
US-11911356-B2 Regulation of mutant TERT by BRAF V600E/map kinase pathway through FOS/GABP in human cancer THE JOHNS HOPKINS UNIVERSITY (US) 2024-02-27 US disclosed
US-20200323805-A1 REGULATION OF MUTANT TERT BY BRAF V600E/MAP KINASE PATHWAY THROUGH FOS/GABP IN HUMAN CANCER THE JOHNS HOPKINS UNIVERSITY 2020-10-15 US disclosed
WO-1995033745-A9 NOVEL COMPOUNDS USEFUL IN MODULATING GENE EXPRESSION OF RETINOID RESPONSIVE GENES AND/OR HAVING ANTI-AP-1 ACTIVITY 1996-01-18 WO disclosed
WO-1995033745-A2 NOVEL COMPOUNDS USEFUL IN MODULATING GENE EXPRESSION OF RETINOID RESPONSIVE GENES AND/OR HAVING ANTI-AP-1 ACTIVITY SRI INTERNATIONAL (US) 1995-12-14 WO disclosed